Evidence map›Paper›PMID 35342386›Full record

ArticleFrontiers in pharmacology2021

A Microphysiological Cell-Culturing System for Pharmacokinetic Drug Exposure and High-Resolution Imaging of Arrays of 3D Microtissues.

Christian Lohasz, Jacqueline Loretan, Dario Sterker, Ekkehard Görlach, Kasper Renggli, Paul Argast, Olivier Frey, Marion Wiesmann, Markus Wartmann, Martin Rausch and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. A cell culture system to model pharmacokinetics using adjustable-volume perfused mixing chambers.Toxicology in vitro : an international journal published in association with BIBRA · 2023
    Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Christian LohaszETH Zürich, Department of Biosystems Science and Engineering, Basel, Switzerland.
Jacqueline LoretanNovartis Institutes for Biomedical Research, Basel, Switzerland.
Dario SterkerNovartis Institutes for Biomedical Research, Basel, Switzerland.
Ekkehard GörlachNovartis Institutes for Biomedical Research, Basel, Switzerland.
Kasper RenggliETH Zürich, Department of Biosystems Science and Engineering, Basel, Switzerland.
Paul ArgastFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Olivier FreyInSphero AG, Schlieren, Switzerland.
Marion WiesmannNovartis Institutes for Biomedical Research, Basel, Switzerland.
Markus WartmannNovartis Institutes for Biomedical Research, Basel, Switzerland.
Martin RauschNovartis Institutes for Biomedical Research, Basel, Switzerland.
Andreas HierlemannETH Zürich, Department of Biosystems Science and Engineering, Basel, Switzerland.
Novartis Institutes for BioMedical ResearchETH Zurich · CHNovartis (Switzerland) · CHFriedrich Miescher Institute · CHInspire · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the pharmacokinetic/pharmacodynamic (PK/PD)-relationship of a drug candidate is key to determine effective, yet safe treatment regimens for patients. However, current testing strategies are inefficient in characterizing

Indexed as

drug testinghigh-resolution imagingmicrophysiological systemspharmacokineticsspheroids

Identifiers

PMID35342386
PMCPMC8954798
OpenAlexW4200105276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.